REPLIGEN CORP (RGEN) insider trading activity (SEC Form 4). Over the trailing 90 days, RGEN insiders filed 0 purchases totalling $0 and 4 sales totalling $2.5M — net SELLING of $2.5M. Most recent filing: Sep 22, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Sep 22, 2026 | Loeillot Olivier | CEO | S SaleOE | — | $180.00 | $977K | filing |
| Sep 8, 2026 | Loeillot Olivier | CEO | S Sale | — | $165.90 | $504K | filing |
| Aug 21, 2026 | Loeillot Olivier | CEO | S SaleOE | — | $180.00 | $977K | filing |
| Jul 17, 2026 | Garland Jason K | CFO | S Sale | — | $150.00 | $80K | filing |
| Jun 26, 2026 | Garland Jason K | CFO | S Sale | — | $145.00 | $106K | filing |